Patrick Waters
PhD FRCPath
Co-Director Autoimmune Neurology Diagnostic Laboratory
CNS autoimmunity, Assay development, Antibody cloning
My research focuses on antibody mediated central nervous system diseases. I am interested in the discovery of new antibody targets, the optimisation of assays to detect antibodies in patients serum and CSF, and understanding the mechanism through which the antibodies cause disease.
Research groups
Websites
-
NHS Specialised Services for Neuromyelitis optica
NHS Specialised Services for Neuromyelitis optica
-
Guthy-Jackson NMO Website
Guthy-Jackson NMO Website
Recent publications
-
Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
Journal article
Ramberger M. et al, (2020), Brain
-
International multicenter examination of MOG antibody assays.
Journal article
WATERS P., (2020), Neurology, Neuroimmunology and Neuroinflammation
-
The clinical profile of NMOSD in Australia and New Zealand.
Journal article
Bukhari W. et al, (2020), J Neurol
-
Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases.
Journal article
Kim Y. et al, (2020), Multiple Sclerosis and Related Disorders, 101939 - 101939
-
An international multicenter examination of MOG antibody assays
Journal article
WATERS P., (2019), Neurology, Neuroimmunology and Neuroinflammation